BRIEF published on 03/27/2025 at 07:50, 1 year 1 month ago Eckert & Ziegler annonce une année record en 2024 Eckert & Ziegler Résultats Financiers 2024 Secteur Médical Produits Isotopiques Prévisions Pour 2025
BRIEF published on 03/27/2025 at 07:50, 1 year 1 month ago Eckert & Ziegler Reports Record Year in 2024 Eckert & Ziegler 2024 Financial Results Medical Segment Isotope Products 2025 Forecast
PRESS RELEASE published on 03/27/2025 at 07:45, 1 year 1 month ago Eckert & Ziegler: Record year 2024 with new all-time highs Eckert & Ziegler SE achieved record sales of €295.8 million in 2024, with significant growth in Medical and Isotope Products segments. Forecasting sales of €320 million and EBIT of €78 million for 2025 Record Sales Eckert & Ziegler SE 2024 Financial Year Medical Segment Isotope Products Segment
BRIEF published on 03/25/2025 at 09:35, 1 year 1 month ago Eckert & Ziegler fournira de l'actinium-225 à Actinium Pharmaceuticals Essais Cliniques Leucémie Myéloïde Aiguë Approvisionnement En Actinium 225 Radiothérapie Ciblée Pénurie Mondiale
BRIEF published on 03/25/2025 at 09:35, 1 year 1 month ago Eckert & Ziegler to Provide Actinium Pharmaceuticals with Actinium-225 Clinical Trials Acute Myeloid Leukemia Actinium-225 Supply Targeted Radiotherapy Global Shortage
PRESS RELEASE published on 03/25/2025 at 09:30, 1 year 1 month ago Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities Eckert & Ziegler SE to supply Actinium Pharmaceuticals with Ac-225 for comprehensive development activities, targeting cancer treatment with radiotherapies Cancer Treatment Eckert & Ziegler SE Radiotherapy Ac-225 Actinium Pharmaceuticals
BRIEF published on 03/20/2025 at 14:05, 1 year 1 month ago Eckert & Ziegler Partner with AtomVie on Lutetium-177 Supply Radiopharmaceuticals Lutetium-177 Theralugand Global Agreement AtomVie Partnership
BRIEF published on 03/20/2025 at 14:05, 1 year 1 month ago Eckert & Ziegler s'associe à AtomVie pour l'approvisionnement en lutétium-177 Produits Radiopharmaceutiques Theralugand Lutécium-177 Accord Mondial Partenariat AtomVie
PRESS RELEASE published on 03/20/2025 at 14:00, 1 year 1 month ago Eckert & Ziegler and AtomVie Global Radiopharma Sign a Global Agreement for Lutetium-177 Supply Eckert & Ziegler SE and AtomVie Global Radiopharma sign a global agreement for Lutetium-177 supply, enhancing radiopharmaceutical development and manufacturing Eckert & Ziegler SE Lutetium-177 Global Agreement AtomVie Global Radiopharma Radiopharmaceutical
BRIEF published on 02/27/2025 at 15:05, 1 year 2 months ago Eckert & Ziegler Forms Strategic Partnership with Bicycle Therapeutics Strategic Partnership Radiopharmaceuticals GMP Facility Radioisotope Supply Bicycle Radio Conjugates
Published on 05/08/2026 at 00:45, 15 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 1 hour ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 1 hour 30 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 1 hour 45 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 22:05, 2 hours 55 minutes ago MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 23:23, 1 hour 36 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 1 hour 45 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 2 hours 54 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 4 hours 17 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 6 hours 13 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 5 hours 45 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 5 hours 45 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 5 hours 53 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 5 hours 53 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 6 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
